Fertility and Sterility
Volume 96, Issue 1 , Pages 79-83, July 2011

An alternative treatment option in tubal ectopic pregnancies with fetal heartbeat: aspiration of the embryo followed by single-dose methotrexate administration

Obstetrics and Gynecology, Division of Reproductive Endocrinology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey

Received 10 October 2010; received in revised form 19 January 2011; accepted 18 February 2011. published online 20 May 2011.

Objective

To present 13 cases of unruptured tubal ectopic pregnancies successfully treated with ultrasound-guided aspiration and local and systemic methotrexate (MTX) administration.

Design

Case series.

Setting

University hospital.

Patient(s)

Thirteen women with an unruptured tubal ectopic pregnancy.

Intervention(s)

Transvaginal ultrasound-guided aspiration of the tubal ectopic pregnancy followed by MTX administration into the gestational sac (half of the calculated total dose of 25 mg/m2) and intramuscular injection (the remaining half of the calculated total dose of 25 mg/m2).

Main Outcome Measure(s)

Recovery of the patients, successful conservative treatment of the tubal ectopic pregnancies with preservation of the fallopian tubes.

Result(s)

Twelve (92%) of 13 women were successfully aborted, without need for salpingectomy or salpingostomy.

Conclusion(s)

Transvaginal ultrasound-guided aspiration of fetus followed by local and systemic methotrexate administration can be safely used to treat unruptured tubal ectopic pregnancies.

Key Words: Fetus aspiration, living, methotrexate, ossification, tubal ectopic pregnancy, unruptured

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 İ.Ç. has nothing to disclose. O.G. has nothing to disclose. P.Ö. has nothing to disclose. R.S. has nothing to disclose. H.G. has nothing to disclose. M.İ. has nothing to disclose.

PII: S0015-0282(11)00691-1

doi:10.1016/j.fertnstert.2011.02.058

Fertility and Sterility
Volume 96, Issue 1 , Pages 79-83, July 2011